SGLT2 inhibitors reduces hospitalization for heart failure regardless of presence of diabetes
A systematic review and meta-analysis of randomized control trials (RCTs) found that sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce hospitalizations and may reduce cardiovascular deaths among people experiencing ...
Apr 11, 2022
0
1